COLO-B.CO
Coloplast B A/S
CopenhagenDKKEQUITY
Healthcare
DELAYED
Last price
438.60
▲ 2.80 (0.64%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
432.90
Prev close
435.80
Day high
438.60
Day low
429.80
Volume
193.99K
Market cap
$98.85B
P/E (TTM)
35.72
52W range
369.70 – 646.60
Trailing performance
Returnvs SPY
1W
+2.40%
+3.8%
1M
+9.98%
+6.2%
3M
+8.67%
+5.6%
6M
-7.68%
-18.7%
YTD
-19.73%
-32.0%
1Y
-27.34%
-47.3%
3Y
-46.95%
-121.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on COLO-B.CO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
67.09M
Total on file
Fundamentals
Market cap$98.85B
Enterprise value$121.74B
Revenue (TTM)$28.44B
Gross profit$19.12B
EBITDA$11.62B
Net income$2.76B
EPS (TTM)$12.28
Free cash flow$7.67B
Total cash$817.00M
Total debt$23.80B
Book value / share$59.37
Shares outstanding207.37M
Float144.57M
Short % of float—
Dividend yield5.24%
Beta (5Y)0.55
Valuation & profitability ratios
Trailing P/E35.72
Forward P/E16.87
PEG ratio1.12
Price / sales—
Price / book7.39
EV / revenue4.28
EV / EBITDA10.47
Gross margin67.23%
Operating margin26.23%
Profit margin9.71%
Return on equity18.53%
Return on assets10.12%
Debt / equity178.07
Current ratio1.56
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Total revenue | $27.03B | $24.50B | $22.58B | $19.43B | +10.3% |
| Operating revenue | $27.03B | $24.50B | $22.58B | $19.43B | +10.3% |
| Cost of revenue | $8.76B | $8.17B | $7.05B | $6.11B | +7.2% |
| Gross profit | $18.27B | $16.33B | $15.53B | $13.31B | +11.9% |
| Research & development | $913.00M | $872.00M | $866.00M | $755.00M | +4.7% |
| Selling, general & admin | $10.07B | $8.63B | $7.80B | $6.25B | +16.6% |
| Total operating expense | $10.98B | $9.48B | $8.62B | $6.96B | +15.8% |
| Operating income | $7.29B | $6.84B | $6.91B | $6.36B | +6.4% |
| Net interest income | -$800.00M | -$605.00M | -$199.00M | -$45.00M | -32.2% |
| Pre-tax income | $6.39B | $6.03B | $6.13B | $6.23B | +6.1% |
| Tax provision | $1.34B | $1.24B | $1.42B | $1.41B | +8.1% |
| Net income | $5.05B | $4.78B | $4.71B | $4.83B | +5.6% |
| Net income to common | $5.05B | $4.78B | $4.71B | $4.83B | +5.6% |
| Basic EPS | 22.46 | 22.21 | 22.14 | 22.67 | +1.1% |
| Diluted EPS | 22.46 | 22.20 | 22.11 | 22.63 | +1.2% |
| EBIT | $7.19B | $6.66B | $6.30B | $6.26B | +7.9% |
| EBITDA | $8.48B | $7.73B | $7.23B | $7.05B | +9.7% |
| Basic shares | 224.90M | 215.40M | 212.50M | 212.80M | +4.4% |
| Diluted shares | 224.90M | 215.50M | 212.80M | 213.20M | +4.4% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $788.00M | $911.00M | $414.00M | $448.00M | -13.5% |
| Cash & short-term investments | $788.00M | $911.00M | $633.00M | $674.00M | -13.5% |
| Accounts receivable | $4.67B | $4.32B | $3.94B | $3.21B | +8.3% |
| Inventory | $3.67B | $3.52B | $3.19B | $2.43B | +4.3% |
| Total current assets | $10.44B | $9.94B | $8.77B | $6.99B | +5.1% |
| Property, plant & equipment | $6.57B | $5.98B | $5.15B | $4.39B | +9.9% |
| Goodwill & intangibles | $30.33B | $31.25B | $22.77B | $3.65B | -3.0% |
| Total assets | $48.07B | $48.16B | $37.45B | $15.84B | -0.2% |
| Total current liabilities | $10.20B | $16.31B | $7.34B | $6.31B | -37.4% |
| Current debt | $5.08B | $7.12B | $1.64B | $2.16B | -28.5% |
| Long-term debt | $16.56B | $11.56B | $16.36B | $0 | +43.3% |
| Total debt | $22.63B | $19.57B | $18.71B | $2.79B | +15.6% |
| Total liabilities | $30.13B | $30.86B | $29.15B | $7.67B | -2.4% |
| Retained earnings | $15.39B | $14.63B | $5.39B | $5.41B | +5.2% |
| Shareholder equity | $17.94B | $17.30B | $8.29B | $8.17B | +3.7% |
| Working capital | $240.00M | -$6.37B | $1.44B | $680.00M | +103.8% |
| Net tangible assets | -$12.39B | -$13.96B | -$14.47B | $4.52B | +11.2% |
| Shares issued | 228.20M | 228.20M | 216.00M | 216.00M | 0.0% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Net income | $7.32B | $6.77B | $6.44B | $6.16B | +8.1% |
| Depreciation & amortisation | $1.29B | $1.07B | $930.00M | $792.00M | +20.7% |
| Change in working capital | -$1.03B | -$893.00M | -$849.00M | -$75.00M | -15.6% |
| Operating cash flow | $2.77B | $4.23B | $5.10B | $5.29B | -34.5% |
| Capital expenditure | -$1.35B | -$1.24B | -$1.14B | -$1.97B | -8.5% |
| Investing cash flow | -$1.34B | -$8.96B | -$11.76B | -$2.01B | +85.1% |
| Share buybacks | — | $0 | -$619.00M | -$500.00M | — |
| Dividends paid | -$4.72B | -$4.25B | -$4.04B | -$3.83B | -11.1% |
| Financing cash flow | -$1.52B | $5.26B | $6.59B | -$3.18B | -128.8% |
| Free cash flow | $1.42B | $2.98B | $3.96B | $3.32B | -52.4% |
| End cash position | $788.00M | $911.00M | $414.00M | $448.00M | -13.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $7.08B | $7.04B | $6.96B | $6.93B | $7.03B | +0.6% |
| Operating revenue | $7.08B | $7.04B | $6.96B | $6.93B | $7.03B | +0.6% |
| Cost of revenue | $2.37B | $2.31B | $2.25B | $2.20B | $2.28B | +2.6% |
| Gross profit | $4.72B | $4.74B | $4.71B | $4.73B | $4.75B | -0.4% |
| Research & development | $254.00M | $247.00M | $239.00M | $239.00M | $219.00M | +2.8% |
| Selling, general & admin | $2.67B | $2.64B | $2.58B | $2.63B | $2.62B | +0.8% |
| Total operating expense | $2.90B | $2.88B | $2.79B | $2.84B | $2.84B | +0.4% |
| Operating income | $1.82B | $1.85B | $1.92B | $1.89B | $1.91B | -1.6% |
| Net interest income | -$39.00M | -$153.00M | -$490.00M | -$316.00M | -$166.00M | +74.5% |
| Pre-tax income | -$1.24B | $1.79B | $1.34B | $1.49B | $1.77B | -169.5% |
| Tax provision | -$273.00M | $394.00M | $537.00M | $579.00M | $725.00M | -169.3% |
| Net income | -$971.00M | $1.40B | $805.00M | $912.00M | $1.04B | -169.5% |
| Net income to common | -$971.00M | $1.40B | $805.00M | $912.00M | $1.04B | -169.5% |
| Basic EPS | -4.31 | 6.20 | 3.57 | 4.05 | 4.63 | -169.5% |
| Diluted EPS | -4.31 | 6.20 | 3.57 | 4.05 | 4.63 | -169.5% |
| EBIT | -$1.06B | $1.96B | $1.83B | $1.81B | $1.97B | -154.0% |
| EBITDA | $2.29B | $2.30B | $2.17B | $2.15B | $2.30B | -0.3% |
| Basic shares | 225.20M | 225.00M | 225.40M | 225.40M | 225.00M | +0.1% |
| Diluted shares | 225.20M | 225.00M | 225.40M | 225.40M | 225.00M | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.07B | $1.13B | $726.00M | $729.00M | $906.00M | -5.2% |
| Cash & short-term investments | $1.07B | $1.13B | $726.00M | $729.00M | $906.00M | -5.2% |
| Accounts receivable | $4.59B | $4.50B | $4.79B | $4.75B | $4.61B | +2.0% |
| Inventory | $3.94B | $3.86B | $3.78B | $3.80B | $3.67B | +2.2% |
| Total current assets | $10.45B | $10.30B | $10.56B | $10.47B | $10.37B | +1.5% |
| Property, plant & equipment | $7.69B | $7.32B | $6.84B | $6.90B | $6.75B | +5.0% |
| Goodwill & intangibles | $27.48B | $30.18B | $29.92B | $31.21B | $30.64B | -9.0% |
| Total assets | $46.65B | $48.80B | $47.88B | $49.15B | $48.34B | -4.4% |
| Total current liabilities | $5.98B | $7.93B | $10.55B | $10.97B | $12.77B | -24.6% |
| Current debt | $1.97B | $3.44B | $6.68B | $6.67B | $7.20B | -42.7% |
| Long-term debt | $21.34B | $20.73B | $16.56B | $16.57B | $16.56B | +2.9% |
| Total debt | $24.23B | $25.10B | $24.21B | $24.26B | $24.76B | -3.5% |
| Total liabilities | $33.81B | $34.99B | $31.43B | $32.21B | $32.88B | -3.4% |
| Retained earnings | $12.95B | $15.03B | $16.81B | $16.29B | $16.52B | -13.9% |
| Shareholder equity | $12.84B | $13.80B | $16.45B | $16.94B | $15.46B | -7.0% |
| Working capital | $4.47B | $2.37B | $3.00M | -$500.00M | -$2.40B | +88.8% |
| Net tangible assets | -$14.63B | -$16.37B | -$13.47B | -$14.27B | -$15.18B | +10.6% |
| Shares issued | 228.20M | 228.20M | 228.20M | 228.20M | 228.20M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.21B | $1.81B | $1.83B | $1.81B | $1.84B | -166.4% |
| Depreciation & amortisation | $3.35B | $345.00M | $343.00M | $344.00M | $328.00M | +870.7% |
| Change in working capital | -$505.00M | $182.00M | -$62.00M | -$1.09B | $172.00M | -377.5% |
| Operating cash flow | $1.47B | $2.23B | $1.63B | $742.00M | $2.01B | -34.3% |
| Capital expenditure | -$449.00M | -$414.00M | -$418.00M | -$310.00M | -$308.00M | -8.5% |
| Investing cash flow | -$612.00M | -$412.00M | -$419.00M | -$309.00M | -$133.00M | -48.5% |
| Dividends paid | $0 | -$4.06B | -$1.13B | $0 | -$3.83B | +100.0% |
| Financing cash flow | -$934.00M | -$1.64B | -$1.18B | -$598.00M | -$1.76B | +43.1% |
| Free cash flow | $1.02B | $1.82B | $1.21B | $432.00M | $1.70B | -44.1% |
| End cash position | $1.07B | $1.13B | $726.00M | $729.00M | $906.00M | -5.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 6.05 | 6.55 | +8.3% |
| Mar 2026 | 5.84 | -0.16 | -102.7% |
| Dec 2025 | 6.07 | 6.32 | +4.2% |
| Sep 2025 | 7.05 | 4.67 | -33.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 5.17 | 5 | $7.36B | +5.7% |
| Next quarter | — | — | $0 | — |
| Current year | 24.73 | 20 | $28.84B | +3.5% |
| Next year | 26.00 | 20 | $30.78B | +6.7% |
Analyst targets & ownership
Mean target$467.10
High target$625.00
Low target$370.00
Implied upside6.50%
Analyst count21
ConsensusHOLD
Strong buy / Buy0 / 3
Hold14
Sell / Strong sell3 / 0
Held by insiders29.79%
Held by institutions32.67%
Institutions holding392
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
433.47
+1.18% from price
SMA 20
432.63
+1.38% from price
SMA 50
409.09
+7.21% from price
SMA 100
409.62
+7.08% from price
SMA 200
471.87
-7.05% from price
EMA 12
433.32
+1.22% from price
EMA 26
426.37
+2.87% from price
EMA 50
419.15
+4.64% from price
RSI (14)
57.4
Neutral
MACD (12,26,9)
6.95
Hist -0.51
ATR (14)
11.25
2.56% of price
Realised vol 30D
30.8%
Annualised
Bollinger upper
444.23
20, 2σ
Bollinger lower
421.03
20, 2σ
50 / 200 cross
Death
409.09 vs 471.87
Trend bias
Below 200
-7.05%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.18
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
30.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-41.0%
Peak to trough
Max drawdown 5Y
-68.5%
Peak to trough
ATR 14
11.25
2.56% of price
Beta (reported)
0.55
5Y monthly, from filing
Dividends & splits
Forward rate$23.00 / yr
Forward yield5.24%
5-year avg yield2.88%
Payout ratio187.60%
Ex-dividend dateMay 18, 2026
Next pay date—
Last split5:1
Split dateDec 19, 2012
Headlines
Apple Cut Its Standard EU App Store Commission From 30% to 26%
Motley Fool · 12m ago
Gundir Announces Gundir365(TM) Postage Promise, Locking In Direct Mail Postage Rates for a Full Year
ACCESS Newswire · 25m ago
Why Keysight Technologies Stock Sank This Week
Motley Fool · 31m ago
Sydney marathon unveils medal with wrong stadium
AFP · 34m ago
Atlassian (TEAM) Stock Looks Near Fair Value After Its 98% Run
Simply Wall St. · 38m ago
Is Vestas Wind Systems (CPSE:VWS) Fully Valued As Earnings Lifted Full Year Guidance?
Simply Wall St. · 38m ago
Clorox (CLX) Could Be 56% Below Fair Value As Valuation Views Split
Simply Wall St. · 38m ago
Red Cat Holdings (RCAT) Expands Blue Ops Integration, Is The Upside Already Priced In?
Simply Wall St. · 38m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.